TRβ activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2 and CEBPA.

Autor: Pan, Xin, Wang, Lan, Yang, Juntang, Li, Yingge, Xu, Min, Liang, Chenxi, Liu, Lulu, Li, Zhongzheng, Xia, Cong, Pang, Jiaojiao, Wang, Mengyuan, Li, Meng, Guo, Saiya, Yan, Peishuo, Ding, Chen, Rosas, Ivan O., Yu, Guoying
Předmět:
Zdroj: Nature Communications; 10/7/2024, Vol. 15 Issue 1, p1-19, 19p
Abstrakt: Aberrant repair underlies the pathogenesis of pulmonary fibrosis while effective strategies to convert fibrosis to normal regeneration are scarce. Here, we found that thyroid hormone is decreased in multiple models of lung injury but is essential for lung regeneration. Moreover, thyroid hormone receptor α (TRα) promotes cell proliferation, while TRβ fuels cell maturation in lung regeneration. Using a specific TRβ agonist, sobetirome, we demonstrate that the anti-fibrotic effects of thyroid hormone mainly rely on TRβ in mice. Cellularly, TRβ activation enhances alveolar type-2 (AT2) cell differentiation into AT1 cell and constrains AT2 cell hyperplasia. Molecularly, TRβ activation directly regulates the expression of KLF2 and CEBPA, both of which further synergistically drive the differentiation program of AT1 cells and benefit regeneration and anti-fibrosis. Our findings elucidate the modulation function of the TRβ-KLF2/CEBPA axis on AT2 cell fate and provide a potential treatment strategy to facilitate lung regeneration and anti-fibrosis. Here, Xin Pan and colleagues found that activation of thyroid hormone receptor-β is necessary for alveolar epithelial cell differentiation during lung repair and regeneration, and confirmed a specific agonist and molecular targets for fibrosis therapy. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: